vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Skyward Specialty Insurance Group, Inc. (SKWD). Click either name above to swap in a different company.
Skyward Specialty Insurance Group, Inc. is the larger business by last-quarter revenue ($385.6M vs $284.0M, roughly 1.4× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 11.2%, a 85.1% gap on every dollar of revenue. On growth, Skyward Specialty Insurance Group, Inc. posted the faster year-over-year revenue change (26.7% vs 9.4%). Over the past eight quarters, Skyward Specialty Insurance Group, Inc.'s revenue compounded faster (20.6% CAGR vs 17.5%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Skyward Specialty Insurance Group, Inc. is a specialty property and casualty insurance provider offering tailored coverage solutions including commercial auto, general liability, professional indemnity, and specialty property policies. It primarily serves small-to-medium enterprises and niche industry segments across the United States, focusing on underwriting complex, hard-to-place risks for underserved client groups.
ACAD vs SKWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $385.6M |
| Net Profit | $273.6M | $43.2M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | 14.2% |
| Net Margin | 96.3% | 11.2% |
| Revenue YoY | 9.4% | 26.7% |
| Net Profit YoY | 90.3% | 200.1% |
| EPS (diluted) | $1.61 | $1.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $385.6M | ||
| Q3 25 | $278.6M | $382.5M | ||
| Q2 25 | $264.6M | $319.9M | ||
| Q1 25 | $244.3M | $328.5M | ||
| Q4 24 | $259.6M | $304.4M | ||
| Q3 24 | $250.4M | $300.9M | ||
| Q2 24 | $242.0M | $279.9M | ||
| Q1 24 | $205.8M | $265.0M |
| Q4 25 | $273.6M | $43.2M | ||
| Q3 25 | $71.8M | $45.9M | ||
| Q2 25 | $26.7M | $38.8M | ||
| Q1 25 | $19.0M | $42.1M | ||
| Q4 24 | $143.7M | $14.4M | ||
| Q3 24 | $32.8M | $36.7M | ||
| Q2 24 | $33.4M | $31.0M | ||
| Q1 24 | $16.6M | $36.8M |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — | ||
| Q1 24 | 88.8% | — |
| Q4 25 | 6.1% | 14.2% | ||
| Q3 25 | 12.8% | 15.8% | ||
| Q2 25 | 12.2% | 15.6% | ||
| Q1 25 | 7.9% | 15.7% | ||
| Q4 24 | 59.1% | 6.1% | ||
| Q3 24 | 12.6% | 15.6% | ||
| Q2 24 | 12.6% | 14.4% | ||
| Q1 24 | 7.4% | 17.7% |
| Q4 25 | 96.3% | 11.2% | ||
| Q3 25 | 25.8% | 12.0% | ||
| Q2 25 | 10.1% | 12.1% | ||
| Q1 25 | 7.8% | 12.8% | ||
| Q4 24 | 55.4% | 4.7% | ||
| Q3 24 | 13.1% | 12.2% | ||
| Q2 24 | 13.8% | 11.1% | ||
| Q1 24 | 8.0% | 13.9% |
| Q4 25 | $1.61 | $1.03 | ||
| Q3 25 | $0.42 | $1.10 | ||
| Q2 25 | $0.16 | $0.93 | ||
| Q1 25 | $0.11 | $1.01 | ||
| Q4 24 | $0.86 | $0.33 | ||
| Q3 24 | $0.20 | $0.89 | ||
| Q2 24 | $0.20 | $0.75 | ||
| Q1 24 | $0.10 | $0.90 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $168.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $1.0B |
| Total Assets | $1.6B | $4.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $168.5M | ||
| Q3 25 | $258.0M | $160.1M | ||
| Q2 25 | $253.6M | $136.6M | ||
| Q1 25 | $217.7M | $112.9M | ||
| Q4 24 | $319.6M | $121.6M | ||
| Q3 24 | $155.1M | $105.6M | ||
| Q2 24 | $177.1M | $73.0M | ||
| Q1 24 | $204.7M | $85.1M |
| Q4 25 | $1.2B | $1.0B | ||
| Q3 25 | $917.3M | $961.4M | ||
| Q2 25 | $822.4M | $899.9M | ||
| Q1 25 | $765.2M | $850.7M | ||
| Q4 24 | $732.8M | $794.0M | ||
| Q3 24 | $577.2M | $797.5M | ||
| Q2 24 | $516.7M | $723.6M | ||
| Q1 24 | $464.0M | $692.3M |
| Q4 25 | $1.6B | $4.8B | ||
| Q3 25 | $1.3B | $4.6B | ||
| Q2 25 | $1.2B | $4.3B | ||
| Q1 25 | $1.1B | $4.0B | ||
| Q4 24 | $1.2B | $3.7B | ||
| Q3 24 | $976.9M | $3.6B | ||
| Q2 24 | $914.1M | $3.4B | ||
| Q1 24 | $855.1M | $3.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $408.1M |
| Free Cash FlowOCF − Capex | — | $402.6M |
| FCF MarginFCF / Revenue | — | 104.4% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | -0.18× | 9.44× |
| TTM Free Cash FlowTrailing 4 quarters | — | $755.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $408.1M | ||
| Q3 25 | $74.3M | $171.4M | ||
| Q2 25 | $64.0M | $88.2M | ||
| Q1 25 | $20.3M | $96.8M | ||
| Q4 24 | $40.4M | $305.1M | ||
| Q3 24 | $63.2M | $168.0M | ||
| Q2 24 | $25.0M | $21.0M | ||
| Q1 24 | $29.1M | $94.3M |
| Q4 25 | — | $402.6M | ||
| Q3 25 | $73.9M | $168.9M | ||
| Q2 25 | — | $87.1M | ||
| Q1 25 | — | $96.6M | ||
| Q4 24 | — | $300.9M | ||
| Q3 24 | $63.2M | $167.6M | ||
| Q2 24 | — | $18.4M | ||
| Q1 24 | — | $94.0M |
| Q4 25 | — | 104.4% | ||
| Q3 25 | 26.5% | 44.2% | ||
| Q2 25 | — | 27.2% | ||
| Q1 25 | — | 29.4% | ||
| Q4 24 | — | 98.8% | ||
| Q3 24 | 25.2% | 55.7% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | 35.5% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | 0.1% | 0.6% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | -0.18× | 9.44× | ||
| Q3 25 | 1.03× | 3.73× | ||
| Q2 25 | 2.40× | 2.27× | ||
| Q1 25 | 1.07× | 2.30× | ||
| Q4 24 | 0.28× | 21.18× | ||
| Q3 24 | 1.93× | 4.58× | ||
| Q2 24 | 0.75× | 0.68× | ||
| Q1 24 | 1.76× | 2.56× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
SKWD
Segment breakdown not available.
